Invention Grant
- Patent Title: Triazolotriazines as kinase inhibitors
- Patent Title (中): 三氮卓嗪作为激酶抑制剂
-
Application No.: US11834226Application Date: 2007-08-06
-
Publication No.: US07683060B2Publication Date: 2010-03-23
- Inventor: Jincong Zhuo , Colin Zhang , Meizhong Xu , Ding-Quan Qian , Wenqing Yao , Ravi Kumar Jalluri
- Applicant: Jincong Zhuo , Colin Zhang , Meizhong Xu , Ding-Quan Qian , Wenqing Yao , Ravi Kumar Jalluri
- Applicant Address: US DE Wilmington
- Assignee: Incyte Corporation
- Current Assignee: Incyte Corporation
- Current Assignee Address: US DE Wilmington
- Agency: Fish & Richardson P.C.
- Agent Christine A. Goddard
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D403/04 ; C07D403/14 ; A61K31/53 ; A61K31/5377 ; A61P35/00
Abstract:
The present invention is directed to [1,2,4]triazolo[4,3-b][1,2,4]triazines, and pharmaceutical compositions thereof, which are inhibitors of kinases such as c-Met and are useful in the treatment of cancer and other diseases related to the dysregulation of kinase pathways.
Public/Granted literature
- US20080039457A1 TRIAZOLOTRIAZINES AS KINASE INHIBITORS Public/Granted day:2008-02-14
Information query
